Feedback Share Discussion Threads

[blueball] 30/9/2015 17:01

Interview with Alan Green at Tradersown

v bullish.

[lr2] 30/9/2015 16:11

Indeed it is.

2.1075p - 2.18p (only 150k available online).

[blueball] 30/9/2015 16:05

Edging higher.

[britstox] 29/9/2015 22:16

Heard this earlier on. There seems to be no end to this company. If I had the money, I would have so much more in it LR2.

[blueball] 29/9/2015 21:45

Directorstalk interview with Dr Balaji.

[britstox] 28/9/2015 22:56

Should be a good week for this company. Still more in this and deservedly.

[lr2] 28/9/2015 21:42

Advfn Podcast 306 featuring FDBK at around 09:45 in.

[blueball] 28/9/2015 13:22

Top riser today and still cheap.

[kenwrong] 28/9/2015 10:48

This is good news, the kidney stone suvrey results were very positive, and as britstox says an enormous market to break into.

[zeuss1] 28/9/2015 08:48

Further to Feedback's £200,000 raise for Texrad development, which is a modest raise considering the developments this year, the joint venture company Stone Checker announced today between Feedback and UK Urology is a very important step forward - see my earlier posts on kidney stones.

7 billion people globally, of these 3-5% will get kidney stones, say 4% = 280 million. Of these, half will be treated by lithotripsy = 140 million cases Of which half is ineffective = 70 million cases. The average cost of Lithotripsy (£2k in the UK but $10k in the USA), say £3k. The total cost of wasted Lithotripsy = £21 billion, over an average life span so £21 billion divided by 70 would give value of world wasted market of around £300m pa.

Stone Checker is just small aspect of TexRAD's potential application - successfully tapping a £300m pa wasted market is a game changer on its own, never mind TexRAD's other applications and joint ventures.

[the stigologist] 28/9/2015 08:37

no numbers as usual

why?

is it because they are pathetically small ?

[blueball] 28/9/2015 08:34

Well 1.5p was the bottom I was right with that.

[britstox] 28/9/2015 08:01

Excellent news. This is great exposure for the company.

[noirua] 22/9/2015 16:45

Imaging tools for medical decision makers

We try to extract every ounce of benefit from medical images. We develop innovative techniques and improved workflows for practitioners involved in medical research and treating patients.


Feedback PLC Dr Balaji Ganeshan on Study Results - July 2015


Updated discussion on Feedback PLC - April 2015

[andya99] 22/9/2015 09:59

Very encouraging. Thanks for sharing.

[lr2] 22/9/2015 01:11

Remember the study of TexRAD on renal cell cancer patients reported on 20th July.



Well the lead researcher, Dr. Andrew Smith, is now applying the technology to melanoma patients.

[the stigologist] 16/9/2015 17:35

Insiders dumping or bucket shops prior to placing ?

[blueball] 16/9/2015 16:39

Back to 1.5p by the look of it.

[britstox] 09/9/2015 08:29

An enormous market to break into.

[britstox] 09/9/2015 08:28

Excellent!

[harris2000] 04/9/2015 02:40

Target price here - Zero pence